IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM

mBio

Volumn 5, Issue 4, 2014, Pages

  Chung, Lawton K ^a   Philip, Naomi H ^b   Schmidt, Valentina A ^c   Koller, Antonius ^c   Strowig, Till ^d   Flavell, Richard A ^d   Brodsky, Igor E ^b   Bliska, James B ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CASPASE 11; EFFECTOR YOPM TYPE III; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; ANIMAL; CELL CULTURE; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM;

YERSINIA PESTIS;

ANIMALS; BACTERIAL PROTEINS; CASPASE 1; CELLS, CULTURED; FEMALE; MACROPHAGES; MICE; MICE, KNOCKOUT; YERSINIA PESTIS;

EID: 84908305287     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01402-14     Document Type: Article

References (41)

1. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819-826. http://dx.doi.org/10.1038/nature06246.
2. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216. http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359.
3. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680. http://dx.doi.org/10.1038/90609.
4. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-832. http://dx.doi.org/10.1016/j.cell.2010.01.040.
5. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack D., Dixit VM. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232. http://dx.doi.org/10.1038/nature04515.
6. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183:787-791. http://dx.doi.org/10.4049/jimmunol.0901363.
7. Miao EA, Warren SE. 2010. Innate immune detection of bacterial virulence factors via the NLRC4 inflammasome. J. Clin. Immunol. 30: 502-506. http://dx.doi.org/10.1007/s10875-010-9386-5.
8. Cunha LD, Zamboni DS. 2013. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria. Front. Cell. Infect. Microbiol. 3:76. http://dx.doi.org/10.3389/fcimb.2013.00076.
9. Bergsbaken T, Fink SL, Cookson BT. 2009. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7:99-109. http://dx.doi.org/10.1038/nrmicro2070.
10. Cornelis GR. 2006. The type III secretion injectisome. Nat. Rev. Microbiol. 4:811-825. http://dx.doi.org/10.1038/nrmicro1526.
11. Viboud GI, Bliska JB. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59: 69-89. http://dx.doi.org/10.1146/annurev.micro.59.030804.121320.
12. Shin H, Cornelis GR. 2007. Type III secretion translocation pores of Yersinia enterocolitica trigger maturation and release of proinflammatory IL-1beta. Cell. Microbiol. 9:2893-2902. http://dx.doi.org/10.1111/j.1462-5822.2007.01004.x.
13. Bergsbaken T, Cookson BT. 2007. Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3(11):e161. http://dx.doi.org/10.1371/journal.ppat.0030161.
14. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell RA, Bliska JB, Medzhitov R. 2010. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7:376-387. http://dx.doi.org/10.1016/j.chom.2010.04.009.
15. Nemeth J, Straley SC. 1997. Effect of Yersinia pestis YopM on experimental plague. Infect. Immun. 65:924-930.
16. Leung KY, Reisner BS, Straley SC. 1990. YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect. Immun. 58:3262-3271.
17. LaRock CN, Cookson BT. 2012. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 12:799-805. http://dx.doi.org/10.1016/j.chom.2012.10.020.
18. Evdokimov AG, Anderson DE, Routzahn KM, Waugh DS. 2001. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J. Mol. Biol. 312:807-821. http://dx.doi.org/10.1006/jmbi.2001.4973.
19. McDonald C, Vacratsis PO, Bliska JB, Dixon JE. 2003. The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J. Biol. Chem. 278:18514-18523. http://dx.doi.org/10.1074/jbc.M301226200.
20. Hentschke M, Berneking L, Belmar Campos C, Buck F, Ruckdeschel K, Aepfelbacher M. 2010. Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation. PLoS One 5(10): e13165. http://dx.doi.org/10.1371/journal.pone.0013165.
21. McCoy MW, Marré ML, Lesser CF, Mecsas J. 2010. The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence. Infect. Immun. 78:2584-2598. http://dx.doi.org/10.1128/IAI.00141-10.
22. McPhee JB, Mena P, Bliska JB. 2010. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infect. Immun. 78:3529-3539. http://dx.doi.org/10.1128/IAI.00269-10.
23. Boland A, Havaux S, Cornelis GR. 1998. Heterogeneity of the Yersinia YopM protein. Microb. Pathog. 25:343-348. http://dx.doi.org/10.1006/mpat.1998.0247.
24. Weissbach L, Settleman J, Kalady MF, Snijders AJ, Murthy AE, Yan YX, Bernards A. 1994. Identification of a human rasGAP-related protein containing calmodulin-binding motifs. J. Biol. Chem. 269:20517-20521.
25. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM. 2011. Non-canonical inflammasome activation targets caspase-11. Nature 479:117-121. http://dx.doi.org/10.1038/nature10558.
26. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM, Fitzgerald KA. 2012. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150: 606-619. http://dx.doi.org/10.1016/j.cell.2012.07.007.
27. Buss C, Müller D, Rüter C, Heusipp G, Schmidt MA. 2009. Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1. Cell. Microbiol. 11:661-677. http://dx.doi.org/10.1111/j.1462-5822.2009.01284.x.
28. McLaughlin LM, Govoni GR, Gerke C, Gopinath S, Peng K, Laidlaw G, Chien YH, Jeong HW, Li Z, Brown MD, Sacks DB, Monack D. 2009. The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration. PLoS Pathog. 5(11):e1000671. http://dx.doi.org/10.1371/journal.ppat.1000671.
29. Kim H, White CD, Sacks DB. 2011. IQGAP1 in microbial pathogenesis: targeting the actin cytoskeleton. FEBS Lett. 585:723-729. http://dx.doi.org/10.1016/j.febslet.2011.01.041.
30. White CD, Erdemir HH, Sacks DB. 2012. IQGAP1 and its binding proteins control diverse biological functions. Cell. Signal. 24:826-834. http://dx.doi.org/10.1016/j.cellsig.2011.12.005.
31. Palmer LE, Hobbie S, Galán JE, Bliska JB. 1998. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNFalpha production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 27:953-965. http://dx.doi.org/10.1046/j.1365-2958.1998.00740.x.
32. Zhang Y, Murtha J, Roberts MA, Siegel RM, Bliska JB. 2008. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages. Infect. Immun. 76: 4299-4310. http://dx.doi.org/10.1128/IAI.00183-08.
33. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardell S, Wei F-Y, Wong W, Kamen R, Seshadri T. 1995. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-411. http://dx.doi.org/10.1016/0092-8674(95)90490-5.
34. Case CL, Kohler LJ, Lima JB, Strowig T, de Zoete MR, Flavell RA, Zamboni DS, Roy CR. 2013. Caspase-11 stimulates rapid flagellinindependent pyroptosis in response to Legionella pneumophila. Proc. Natl. Acad. Sci. U. S. A. 110:1851-1856. http://dx.doi.org/10.1073/pnas.1211521110.
35. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. 1998. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92:501-509. http://dx.doi.org/10.1016/S0092-8674(00)80943-5.
36. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003. http://dx.doi.org/10.1126/science.7535475.
37. Li S, Wang Q, Chakladar A, Bronson RT, Bernards A. 2000. Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1. Mol. Cell. Biol. 20:697-701. http://dx.doi.org/10.1128/MCB.20.2.697-701.2000.
38. Celada A, Gray PW, Rinderknecht E, Schreiber RD. 1984. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160:55-74. http://dx.doi.org/10.1084/jem.160.1.55.
39. Ryndak MB, Chung H, London E, Bliska JB. 2005. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infect. Immun. 73:2433-2443. http://dx.doi.org/10.1128/IAI.73.4.2433-2443.2005.
40. Pujol C, Bliska JB. 2003. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect. Immun. 71:5892-5899. http://dx.doi.org/10.1128/IAI.71.10.5892-5899.2003.
41. Simonet M, Falkow S. 1992. Invasin expression in Yersinia pseudotuberculosis. Infect. Immun. 60:4414-4417.